Sir, Resistance to vancomycin in Enterococcus faecium and Enterococcus faecalis is due to acquired operon structures of two types, namely the D-alanyl-D-lactate and D-alanyl-D-serine operons named for the specific ligase they harbour. The former group consists of the vanA, vanB, vanD and vanM operons and the latter group consists of the vanE, vanG, vanL and vanN operons.
Sir, Resistance to vancomycin in Enterococcus faecium and Enterococcus faecalis is due to acquired operon structures of two types, namely the D-alanyl-D-lactate and D-alanyl-D-serine operons named for the specific ligase they harbour. The former group consists of the vanA, vanB, vanD and vanM operons and the latter group consists of the vanE, vanG, vanL and vanN operons. 1 -5 The D-Ala-D-Lac operons can be carried on plasmids or on the chromosome while the D-Ala-D-Ser operons are chromosomally located except for vanN, which has been found on a plasmid. 5 To date vanN has only been described twice, from E. faecium isolated in 2008 from a patient in France 4 and from E. faecium isolated from a chicken meat sample collected in Japan in 2011. 5 The vanN operons were identical except for a single non-synonymous substitution in the vanS N gene.
A 51-year-old male with tibial and femoral artery occlusion on the right ankle was scheduled for angiography with revascularization. Three weeks later the patient presented at hospital with cellulitis in the right heel and ischaemia in the right ankle wound, which on microbial sampling yielded Escherichia coli, Stenotrophomonas maltophilia and Pantoea agglomerans. Ertapenem treatment was begun and 4 days later trimethoprim/sulfamethoxazole was added. Treatment continued for a further 15 days; the patient was then admitted for revascularization, and the infection was cured successfully. At admission screening (rectal) E. faecium N12-0493 was isolated and was determined by Etest to have a vancomycin MIC of 16 mg/L and a teicoplanin MIC of 0.5 mg/L. Additional testing by Vitek 2 (AST-GP67) showed E. faecium N12-493 was resistant to vancomycin and clindamycin, had intermediate susceptibility to ciprofloxacin, quinupristin/dalfopristin and nitrofurantoin, and was susceptible to ampicillin, high-level gentamicin, levofloxacin, linezolid, tetracycline and tigecycline. No further antimicrobial therapy was started after the procedure. MLST analysis revealed a unique profile, which was assigned ST955 (www.efaecium.mlst.net). ST955 did not cluster with the classical hospital-associated strain types (formerly known as CC17). PCR analysis revealed E. faecium N12-0493 was positive for the E. faecium ddl gene and vanN genes. The putative translation product (149 residues) of the vanN amplicon sequence shared 94% identity with the VanN protein. To identify the genetic context of the complete vanN operon, the genome of E. faecium N12-0493 was completely sequenced using Illumina technology. The assembled reads and the partial vanN sequence of E. faecium N12-0493 were further assembled using the Seqman Pro module of Lasergene 10 (DNASTAR, Madison, WI, USA). In this way a single 137 817 bp circular sequence, designated pEfm12493, was assembled from five contigs, ranging from 2222 to 90 738 bp (mean ¼ 27.6 kb), with confirmation by standard PCR and sequencing ( Figure 1 ). A total of 127 ORFs were annotated using Prokka 6 and manual BLAST analysis (http://blast. ncbi.nlm.nih.gov/Blast.cgi) and are listed in Table S1 (available as Supplementary data at JAC Online). Plasmid pEfm12493 was assigned GenBank accession number KP342511.
Approximately half of pEfm12493 has synteny with and shares 86%-92% nucleotide identity with large parts of the related plasmids p1 from E. faecium AUS0004, p2 from E. faecium AUS0085 and pQY082 from Enterococcus mundtii QU 25 ( Figure 1 ). 7 This area includes genes involved in replication (repR, prgN), genes involved in conjugative transfer (traE1, virD4, virB4, pilus assembly protein genes), genes encoding three sortases and genes encoding two topoisomerases. Some regions in this area not related to the above-mentioned plasmids include a 13 kb region harbouring genes encoding a carboxypeptidase, a two-component system, a XerS-like recombinase and ParA1, and two different regions with group II intron reverse transcriptase genes, the first of which (rt1) interrupts the virB4 gene and the second of which (rt2) interrupts a peptidase gene. The other half of pEfm12493 includes the vanN operon, a sulphur metabolism operon, several cell surface protein genes, genes encoding an ABC transporter and its cognate regulator, a second different parA gene (parA2) and seven defective ISs. The ISs are presumed to be defective due to being only partial (remnant) or due to mutation in the transposase(s) that causes frameshifts and/or internal stop codons. The E. faecium N12-0493 vanN operon itself shares 93% nucleotide identity with previously described vanN operons, with the proteins sharing between 92% and 98% identity, and thus pEfm12493 encodes a vanN variant, vanN 12493 . There are also two complete type II toxin-antitoxin (TA) loci (MazEF-like and RelBE-like) and a separate RelB-like antitoxin gene in this area. The TA loci can act as plasmid addiction systems to ensure the stable maintenance and inheritance of pEfm12493. The vanN operon was reported to be transferable to a suitable E. faecium recipient, albeit at low frequency (10 210 ). 4 We could not successfully detect transfer of vanN 12493 to E. faecium GE-1; Nomura et al. 5 also could not detect vanN transfer. However, we also note, as described above, that the pEfm12493 virB4 ATPase gene is interrupted by the rt1 gene and thus conjugative transfer functions may be compromised (Figure 1) .
The vanN operon is the first D-Ala-D-Ser operon to be found on a plasmid and only the second to be transferred. 4 This is the first report of the complete sequence of a plasmid harbouring vanN, and it would be of interest to know the genetic context of the previously reported vanN operons, given they were reported to be on plasmids estimated to be 150 -160 kb in size, close to the 139 kb of pEfm12493.
Sir, Most non-typhoidal salmonella infections are self-limiting, but antibiotics can be life-saving for vulnerable patients and invasive disease. Salmonella enterica may exhibit resistance to quinolones and cephalosporins, but carbapenem resistance is rarely reported. Non-duplicate isolates (n¼ 126) of cefotaxime-resistant (MICs .1 mg/L) non-typhoidal S. enterica were screened by disc testing for ertapenem resistance. Briefly, 0.5 McFarland standard cell suspensions in Iso-Sensitest broth were inoculated onto MuellerHinton agar plates and 10 mg ertapenem discs were added. Inhibition zone diameters that measured ≤27 mm after 18 h of incubation at 378C were considered resistant compared with positive controls (not salmonellae) producing NDM-1, KPC, VIM, IMP or OXA-48-like carbapenemases. In addition, 2597 S. enterica isolates from patients with a history of travel to North Africa, the Middle East or the Indian subcontinent (all cephalosporin susceptible) were screened retrospectively. A further 266 S. enterica serovar Typhi, 157 S. enterica serovar Paratyphi A and 10 S. enterica serovar Paratyphi B were screened as part of routine susceptibility testing for high-level temocillin resistance (MICs .128 mg/L; a marker for OXA-48-like enzymes) 2 by breakpoint testing using IsoSensitest agar. The MICs were determined by Etest w (bioMérieux, Basingstoke, UK) and interpreted using BSAC criteria (http://bsac. org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013_final. pdf). Carbapenemase genes (KPC, OXA-48-like, NDM, IMP, VIM, GIM, SIM and SPM) were sought by in-house PCRs with gene variants identified by amplicon sequencing. Non-susceptible isolates were used as plasmid donors in electro-transformation to E. coli Alpha-Select cells (Bioline, London, UK) with the transformants selected on Iso-Sensitest agar containing 128 mg/L ampicillin onto which a 10 mg ertapenem disc had been placed.
One of the 126 cefotaxime-resistant isolates showed reduced ertapenem susceptibility. S. enterica serovar Senftenberg strain H083340277 isolated in 2008 from the faeces of an outpatient with an unknown travel history was resistant to cefotaxime and ceftazidime (MICs .256 mg/L) and to ertapenem (MIC ¼ 2 mg/L), but was susceptible to meropenem and imipenem (MICs ¼ 2 mg/L) ( Table 1) . A bla NDM-1 gene was identified in this isolate. NDM carbapenemases are associated with a diverse range of plasmid backbones; therefore, the total genomic DNA of the NDM plasmid transformant was sequenced to .30× coverage on a HiSeq sequencing system (Illumina, Little Chesterford, UK). The reads were assembled into contigs using VelvetOptimiser (https://github.com/VictorianBioinformatics-Consortium/VelvetOptimiser.git), of which three contigs encoding the NDM plasmid were subtracted from the known E. coli host genome and linked by PCR-based gap closure and Sanger DNA sequencing to determine that bla NDM-1 was located on a 53 133 bp complete plasmid sequence. SNP-calling using Bowtie2 (http://bowtie-bio.sourceforge.net/bowtie2) and SAMtools (http://samtools.sourceforge.net) showed 99.7% identity to an IncX3-type bla NDM-1 plasmid from a Raoultella planticola isolated in China (GenBank KF877335), with only 13 SNPs to distinguish them. In both plasmids, bla NDM-1 was flanked upstream by ISAba125 (interrupted by IS5), with the bleomycin resistance gene ble MBL located downstream and with bla SHV-12 as the only other co-resident resistance gene.
Temocillin MICs .128 mg/L were observed for two isolates from 2013: S. enterica serovar Typhimurium definitive phage type 193 strain H132980529 from an inpatient with diarrhoea and a history of travel to Africa and S. enterica serovar Paratyphi B phage type Dundee strain H134000562 from an inpatient with diarrhoea and vomiting reporting no recent travel. Both isolates showed reduced susceptibility to cefotaxime (MICs 2 mg/L) and ceftazidime susceptibility (MICs 0.5 mg/L), indicating that there were no co-resident ESBL or AmpC genes; they showed intermediate susceptibility to ertapenem (MICs 1 mg/L), and susceptibility to meropenem and imipenem (MICs 0.25 -0.5 mg/L) ( Table 1) . bla OXA-48 was identified in both isolates. Previous studies have shown that the international dissemination of bla OXA-48 is largely due to a single plasmid, pOXA-48a. 3 PCR for repA, traU and parA,
